OpenAI Blog
Jun 3
Introducing new capabilities to GPT-Rosalind
GPT-Rosalind advances life sciences research with enhanced biological reasoning, medicinal chemistry expertise, genomics analysis, and experimental workflow capabilities.
Introducing GPT-Rosalind for life sciences research
OpenAI introduces GPT-Rosalind, a frontier reasoning model built to accelerate drug discovery, genomics analysis, protein reasoning, and scientific research workflows.
Related stories
OpenAI Blog
May 29
Strengthening societal resilience with Rosalind Biodefense
OpenAI launches Rosalind Biodefense, expanding trusted access to GPT-Rosalind for vetted developers and U. S.
OpenAI Blog
Aug 22, 2025
Accelerating life sciences research
Discover how a specialized AI model, GPT-4b micro, helped OpenAI and Retro Bio engineer more effective proteins for stem cell therapy and longevity research.
OpenAI Blog
Nov 20, 2025
Early experiments in accelerating science with GPT-5
OpenAI introduces the first research cases showing how GPT-5 accelerates scientific progress across math, physics, biology, and computer science. Explore how AI and researchers collaborate to generate proofs, uncover new insights, and reshape the pace of discovery.
OpenAI Blog
Jun 17, 2024
Using GPT-4o reasoning to transform cancer care
Color Health is working with OpenAI to pioneer a new way of accelerating cancer patients’ access to treatment. Their new Cancer Copilot application uses GPT-4o to identify missing diagnostics and create tailored workup plans, enabling healthcare providers to make evidence-based decisions about cancer screening and treatment.
OpenAI Blog
Oct 23, 2025
Consensus accelerates research with GPT-5 and Responses API
Consensus uses GPT-5 and OpenAI’s Responses API to power a multi-agent research assistant that reads, analyzes, and synthesizes evidence in minutes—helping over 8 million researchers accelerate scientific discovery.
OpenAI Blog
Dec 16, 2025
Measuring AI’s capability to accelerate biological research
OpenAI introduces a real-world evaluation framework to measure how AI can accelerate biological research in the wet lab. Using GPT-5 to optimize a molecular cloning protocol, the work explores both the promise and risks of AI-assisted experimentation.
OpenAI Blog
Jun 17
A near-autonomous AI chemist improves a challenging reaction in medicinal chemistry
OpenAI and Molecule. one show how a near-autonomous AI chemist using GPT-5.
arXiv AI
Aug 5
MDArena: Evaluating Coding Agents on Realistic Molecular Dynamics Workflows
arXiv:2608. 02642v1 Announce Type: cross Abstract: Accelerating scientific discovery is among the most consequential applications of AI, and computational biomolecular simulation stands out as a particularly promising target within this broader effort.
OpenAI Blog
Mar 5
Introducing GPT-5.4
Introducing GPT-5. 4, OpenAI’s most most capable and efficient frontier model for professional work, with state-of-the-art coding, computer use, tool search, and 1M-token context.
OpenAI Blog
Jul 29
Accelerating scientific discovery with ChatGPT for Academic Researchers
OpenAI is giving 100,000 academic researchers free access to ChatGPT's most advanced AI models to accelerate scientific research, collaboration, and discovery.
arXiv Machine Learning
Jul 23
Model Gateway: Management Platform for Model-Driven Drug Discovery
arXiv:2512. 05462v2 Announce Type: replace-cross Abstract: Pharmaceutical drug discovery demands machine learning (ML) infrastructure that goes beyond general-purpose Machine Learning Operations (MLOps): inference-time composition of multiple models for multi-parameter optimization (MPO), version management for physics-based models without serialized ML artifacts, enterprise compound library precomputation, and governance structured around scientific organizational units rather than generic access controls.